Literature DB >> 17604610

Effect of a high-fat meal on absorption and disposition of lipophilic compounds: the importance of degree of association with triglyceride-rich lipoproteins.

Pavel Gershkovich1, Amnon Hoffman.   

Abstract

Following a high-fat meal, triglyceride-rich lipoproteins (TRL) are assembled in the gut and absorbed via the lymph into the blood circulation, producing a temporal hyperlipidemia. The purpose of this study is to verify the hypothesis that this transient acute postprandial hyperlipidemia affects the pharmacokinetics of lipophilic drugs on both absorption and disposition levels by the same underlying mechanism, namely the association of active lipophilic compounds with TRL in the plasma (disposition) or within the enterocyte (lymphatic transport). This concept was assessed in rats using two model compounds, DDT with high affinity to chylomicrons and diazepam which does not bind to chylomicrons. Oral administration of peanut oil significantly increased the AUC of plasma DDT concentrations following its IV bolus administration in comparison to a water treated group. On the other hand, the AUC of diazepam following IV bolus administration was the same in oil and water treated rats. While DDT is known to have significant lymphatic bioavailability, diazepam has negligible intestinal lymphatic transport (0.014+/-0.004% of a given dose). In conclusion, lipophilic molecules that bind extensively to TRL will be prone to both intestinal lymphatic transport and to post-absorptive changes in disposition (decrease in clearance and volume of distribution) following a high-fat meal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17604610     DOI: 10.1016/j.ejps.2007.05.109

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  12 in total

Review 1.  Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.

Authors:  Joseph M Custodio; Chi-Yuan Wu; Leslie Z Benet
Journal:  Adv Drug Deliv Rev       Date:  2007-11-28       Impact factor: 15.470

2.  Intestinal lymphatic transport enhances the post-prandial oral bioavailability of a novel cannabinoid receptor agonist via avoidance of first-pass metabolism.

Authors:  Natalie L Trevaskis; David M Shackleford; William N Charman; Glenn A Edwards; Anne Gardin; Silke Appel-Dingemanse; Olivier Kretz; Bruno Galli; Christopher J H Porter
Journal:  Pharm Res       Date:  2009-03-12       Impact factor: 4.200

3.  A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray.

Authors:  C G Stott; L White; S Wright; D Wilbraham; G W Guy
Journal:  Eur J Clin Pharmacol       Date:  2012-10-04       Impact factor: 2.953

Review 4.  A Review of Food-Drug Interactions on Oral Drug Absorption.

Authors:  Jianyuan Deng; Xiao Zhu; Zongmeng Chen; Chun Ho Fan; Him Shek Kwan; Chi Ho Wong; Ka Yi Shek; Zhong Zuo; Tai Ning Lam
Journal:  Drugs       Date:  2017-11       Impact factor: 9.546

5.  Demonstration of ATP-dependent, transcellular transport of lipid across the lymphatic endothelium using an in vitro model of the lacteal.

Authors:  Alana L Reed; Sydney A Rowson; J Brandon Dixon
Journal:  Pharm Res       Date:  2013-11-20       Impact factor: 4.200

Review 6.  Lipophilic Conjugates of Drugs: A Tool to Improve Drug Pharmacokinetic and Therapeutic Profiles.

Authors:  Sifei Han; Lianghe Mei; Tim Quach; Chris Porter; Natalie Trevaskis
Journal:  Pharm Res       Date:  2021-08-31       Impact factor: 4.200

Review 7.  Bioaccessibility of polycyclic aromatic hydrocarbons: relevance to toxicity and carcinogenesis.

Authors:  Kelly L Harris; Leah D Banks; Jane A Mantey; Ashley C Huderson; Aramandla Ramesh
Journal:  Expert Opin Drug Metab Toxicol       Date:  2013-07-31       Impact factor: 4.481

Review 8.  Current methods for predicting human food effect.

Authors:  Kimberley A Lentz
Journal:  AAPS J       Date:  2008-05-24       Impact factor: 4.009

9.  The effect of a high-fat breakfast on the pharmacokinetics of moxidectin in healthy male subjects: a randomized phase I trial.

Authors:  Joan M Korth-Bradley; Virginia Parks; Stephan Chalon; Ian Gourley; Kyle Matschke; Karine Cailleux; Serge Fitoussi; Lawrence Fleckenstein
Journal:  Am J Trop Med Hyg       Date:  2012-01       Impact factor: 2.345

Review 10.  Improving In Vivo Efficacy of Bioactive Molecules: An Overview of Potentially Antitumor Phytochemicals and Currently Available Lipid-Based Delivery Systems.

Authors:  Lamia Mouhid; Marta Corzo-Martínez; Carlos Torres; Luis Vázquez; Guillermo Reglero; Tiziana Fornari; Ana Ramírez de Molina
Journal:  J Oncol       Date:  2017-05-07       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.